MoneyWorks4Me

Net sales declined -9.63%  to  Rs. 3135.40 million from Rs. 3469.50 millions.The Net Loss for the quarter ended September 2025 is Rs. -100.80 millions as compared to Net Profit of Rs. 80.20 millions of corresponding quarter ended September 2024Operating profit for the quarter ended September 2025 decreased to 352.40 millions as compared to 616.40 millions of corresponding quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 3135.40 3469.50 -9.63 6326.90 7104.40 -10.94 12837.60 12889.20 -0.40
Other Income 4.90 3.20 53.13 14.70 17.00 -13.53 91.40 53.70 70.20
PBIDT 352.40 616.40 -42.83 932.50 1052.60 -11.41 2129.80 -896.90 -337.46
Interest 208.30 282.80 -26.34 447.30 591.50 -24.38 1148.10 1059.70 8.34
PBDT 144.10 333.60 -56.80 485.20 461.10 5.23 981.70 -3853.00 -125.48
Depreciation 244.90 253.40 -3.35 480.70 504.10 -4.64 992.50 1030.30 -3.67
PBT -100.80 80.20 -225.69 4.50 -43.00 -110.47 -10.80 -4883.30 -99.78
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 785.40 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 785.40 0.00
PAT -100.80 80.20 -225.69 4.50 -43.00 -110.47 -10.80 -5668.70 -99.81
Equity 444.70 402.10 10.59 444.70 402.10 10.59 402.50 360.00 11.81
PBIDTM(%) 11.24 17.77 -36.74 14.74 14.82 -0.52 16.59 -6.96 -338.42
Peers
Company Name CMP
Sun Pharma. Inds. 1848.00
Dr. Reddys Labs. 1198.65
Cipla 1408.75
Lupin 2084.00
Zydus Lifesciences 1190.50
View more..